Franziska M. Ippen

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Methodological considerations in the assessment of hemizygous CDKN2A/B deletions in meningioma and IDH-mutant glioma.

Methodological considerations in the assessment of hemizygous CDKN2A/B deletions in meningioma and IDH-mutant glioma.

Journal: Neuro-oncology

Published: July 06, 2026

Mental health and suicidality in glioblastoma patients in germany - a multicenter cross-sectional observational study protocol (SHINE-GLIO Study).

Mental health and suicidality in glioblastoma patients in germany - a multicenter cross-sectional observational study protocol (SHINE-GLIO Study).

Journal: Neurological research and practice

Published: June 29, 2026

Professional Grief, Burnout and Coping among Neuro-Oncologists: A Cross-Sectional Online Study (PROGRESS).

Professional Grief, Burnout and Coping among Neuro-Oncologists: A Cross-Sectional Online Study (PROGRESS).

Journal: Neuro-oncology

Published: April 16, 2026

Hemizygous deletion of CDKN2A/B in IDH-mutated glioma: Prognostic impact when adjusting for clinical factors.

Hemizygous deletion of CDKN2A/B in IDH-mutated glioma: Prognostic impact when adjusting for clinical factors.

Journal: Neuro-oncology advances

Published: February 26, 2026

Preventive strategies against brain metastases: current state of the art and future directions.

Preventive strategies against brain metastases: current state of the art and future directions.

Journal: Neurological research and practice

Published: December 01, 2025

Voxel-accurate MRI-microscopy Correlation Enables AI-powered Prediction of Brain Disease States.

Voxel-accurate MRI-microscopy Correlation Enables AI-powered Prediction of Brain Disease States.

Journal: Theranostics

Published: September 15, 2025

Loss of global DNA hypermethylation is prognostic in IDH-mutant and 1p/19q-codeleted oligodendrogliomas.

Loss of global DNA hypermethylation is prognostic in IDH-mutant and 1p/19q-codeleted oligodendrogliomas.

Journal: Acta neuropathologica

Published: August 26, 2025

The prognostic impact of CDKN2A/B hemizygous deletions in meningioma.

The prognostic impact of CDKN2A/B hemizygous deletions in meningioma.

Journal: Neuro-oncology

Published: August 13, 2025

Outcome-associated factors in a molecularly defined cohort of central neurocytoma.

Outcome-associated factors in a molecularly defined cohort of central neurocytoma.

Journal: Acta neuropathologica

Published: February 28, 2025

Differentiating Glioma Recurrence and Pseudoprogression by APTw CEST MRI.

Differentiating Glioma Recurrence and Pseudoprogression by APTw CEST MRI.

Journal: Investigative radiology

Published: December 07, 2024

The prognostic impact of CDKN2A/B hemizygous deletions in IDH-mutant glioma.

The prognostic impact of CDKN2A/B hemizygous deletions in IDH-mutant glioma.

Journal: Neuro-oncology

Published: November 12, 2024

IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spread.

IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spread.

Journal: Acta neuropathologica

Published: October 22, 2024

Showing 1-12 of 32

Last Updated: 09/26/2026